For citations:
Murashkin N.N., Bakulev A.L., Gorodnichev P.V., Zaslavskiy D.V., Ziganshin O.R., Kokhan M.M., Koshkin S.V., Maksimova A.A., Kovaleva Yu.S., Pak T.E., Sidorenko O.A., Sonin D.B., Khalilov B.V., Khotko A.A., Artem’eva A.V., Eremeeva A.V., Zinkina A.V., Lin’kova Yu.N., Kolosova E.S., Lutskiy A.A., Fokina E.A. Efficacy and Safety of Netakimab in Children and Adolescents with Moderate-to-Severe Plaque Psoriasis: Results of the Core Treatment Period (12 Weeks) of the Randomized Placebo-Controlled Phase III Clinical Trial BCD-085-16/PLANETA-KIDS. Current Pediatrics. 2026;25(3):173–188. https://doi.org/10.15690/vsp.v25i3.3056
Views PDF_MIN (Eng): 21
JATS XML
Email this article 
